| Date Filed | Type | Description |
| 06/16/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 12/23/2021 |
4
| Shearman Mark S (EVP, Chief Scientific Officer) has filed a Form 4 on Editas Medicine, Inc.|
Txns:
| Granted 9,084 shares
@ $0 |
|
| 06/16/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/16/2021 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/18/2020 |
4
| Shearman Mark S (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Paid exercise price by delivering 5,723 shares
@ $5.77, valued at
$33k
|
|
| 08/07/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/19/2019 |
4
| Shearman Mark S (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 39,000 shares
@ $0
Granted 52,000 options to buy
@ $3, valued at
$156k
|
|
| 12/18/2018 |
4
| Shearman Mark S (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Sold 3,000 shares
@ $3.3509, valued at
$10.1k
|
|
| 07/27/2018 |
4
| Shearman Mark S (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 85,000 options to buy
@ $4.25, valued at
$361.3k
|
|
| 07/18/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2016 |
4
| Shearman Mark S (Chief Scientific Officer) has filed a Form 4 on APPLIED GENETIC TECHNOLOGIES CORP|
Txns:
| Granted 50,000 options to buy
@ $15.57, valued at
$778.5k
|
|